| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...510999P |
| P356 | DOI | 10.1371/JOURNAL.PONE.0010999 |
| P932 | PMC publication ID | 2882323 |
| P698 | PubMed publication ID | 20544017 |
| P5875 | ResearchGate publication ID | 44669304 |
| P50 | author | Dominique Heymann | Q43131742 |
| P2093 | author name string | Marie-Françoise Heymann | |
| Anne-Laure Bouffaut | |||
| Elisabeth Cassagnau | |||
| Franck Duteille | |||
| François Gouin | |||
| Françoise Rédini | |||
| Frédéric Deschaseaux | |||
| Julie Rousseau | |||
| Pierre Perrot | |||
| Valérie Trichet | |||
| P2860 | cites work | Mesenchymal stem cells: flip side of the coin | Q37390208 |
| Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma | Q37409192 | ||
| Angiogenesis, adipokines and breast cancer | Q37516876 | ||
| Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. | Q39864787 | ||
| Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma | Q39894724 | ||
| Isolation and characterisation of cancer stem cells from canine osteosarcoma | Q40081869 | ||
| An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma | Q40185368 | ||
| Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells | Q40216419 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype | Q40310331 | ||
| Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice | Q40354761 | ||
| Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis | Q40801693 | ||
| Predictive value of serum immunosuppressive acidic protein for lung metastasis after amputation of murine osteosarcoma of the lower limb | Q40878264 | ||
| Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. | Q41613919 | ||
| Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption | Q45869910 | ||
| Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 | ||
| Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells | Q48012614 | ||
| One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23 | Q28294341 | ||
| Molecular biology of bone metastasis | Q30444749 | ||
| 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation | Q30445896 | ||
| Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells | Q33588841 | ||
| Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression | Q33944735 | ||
| Fat grafting to the breast revisited: safety and efficacy | Q34575972 | ||
| Origin and differentiation of human and murine stroma | Q34633459 | ||
| Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells | Q34673832 | ||
| Stem-like cells in bone sarcomas: implications for tumorigenesis | Q34769927 | ||
| Bone and fat: old questions, new insights | Q35774928 | ||
| Clinical development of anti-RANKL therapy | Q35901092 | ||
| Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma | Q36238078 | ||
| Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures | Q37014076 | ||
| Concise review: adult multipotent stromal cells and cancer: risk or benefit? | Q37128260 | ||
| Autologous fat transfer--a review of the literature with a focus on breast cancer surgery | Q37291692 | ||
| Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle | Q37315780 | ||
| Proteases and bone remodelling | Q37337224 | ||
| Autologous fat transfer in reconstructive breast surgery: indications, technique and results. | Q51081875 | ||
| Autologous fat transfer: controversies and current indications for breast surgery. | Q51850382 | ||
| A model of tumor cell dormancy: Effects of anesthesia and surgery | Q51869977 | ||
| Autologous fat graft in radiated tissue prior to alloplastic reconstruction of the breast: report of two cases. | Q54667612 | ||
| Late relapse in osteosarcoma | Q56997874 | ||
| Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report | Q57008750 | ||
| Cysteine protease production by human osteosarcoma cells (MG63, SAOS2) and its modulation by soluble factors | Q61978445 | ||
| Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 | ||
| Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience | Q67530667 | ||
| Facial recontouring with lipostructure | Q73322066 | ||
| Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis | Q73483291 | ||
| Microvascular angiogenesis and apoptosis in the survival of free fat grafts | Q74170959 | ||
| Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma | Q77337118 | ||
| Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols | Q77579162 | ||
| Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone | Q79317200 | ||
| The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities | Q80065296 | ||
| [Lipomodelling for correction of breast conservative treatment sequelae. Medicolegal aspects. Expert opinion on five problematic clinical cases] | Q80135656 | ||
| [Efficacy of lipomodelling for the management of sequelae of breast cancer conservative treatment] | Q80155740 | ||
| Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway | Q80331559 | ||
| Late recurrence in primary region of parosteal osteosarcoma: a case report | Q80579983 | ||
| time dependency of prognostic factors in patients with stage II osteosarcomas | Q80590434 | ||
| Fat for breast: where are we? | Q81920160 | ||
| Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy | Q83787143 | ||
| Complexes of organic acids with calcium phosphate: the von Kossa stain as a clue to the composition of bone mineral | Q93701459 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | e10999 | |
| P577 | publication date | 2010-06-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence | |
| P478 | volume | 5 |
| Q37718453 | Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. |
| Q33618863 | Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway. |
| Q50980351 | Application of a three-dimensional graft of autologous osteodifferentiated adipose stem cells in patients undergoing minimally invasive transforaminal lumbar interbody fusion: clinical proof of concept. |
| Q48120956 | Biology of Bone Sarcomas and New Therapeutic Developments |
| Q35568502 | Cell-assisted lipotransfer. |
| Q52370993 | Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma. |
| Q47104412 | Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development. |
| Q37855742 | Concise review: mesenchymal tumors: when stem cells go mad. |
| Q64099565 | Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation |
| Q39037470 | Development of a cyclosporin-A-induced immune tolerant rat model to test marrow allograft cell type effects on bone repair |
| Q36558616 | Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model? |
| Q38955517 | Drugs in early clinical development for the treatment of osteosarcoma |
| Q53131045 | Effect of ASCs on the graft survival rates of fat particles in rabbits. |
| Q47191411 | Effect of Adipose-Derived Stem Cells on Head and Neck Squamous Cell Carcinoma. |
| Q37962606 | Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis |
| Q45337938 | Evaluation of fat grafting safety in patients with intraepithelial neoplasia: a matched-cohort study |
| Q96306241 | Exosomes Secreted by Adipose-Derived Mesenchymal Stem Cells Foster Metastasis and Osteosarcoma Proliferation by Increasing COLGALT2 Expression |
| Q48131192 | Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis |
| Q37744842 | Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting. |
| Q41485550 | Increased risk of recurrence associated with certain risk factors in breast cancer patients after DIEP-flap reconstruction and lipofilling-a matched cohort study with 200 patients |
| Q89896202 | Lactate in Sarcoma Microenvironment: Much More than just a Waste Product |
| Q42930678 | Latissimus dorsi flap invasion by ductal breast carcinoma after lipofilling |
| Q57580723 | Locoregional recurrence risk after lipofilling in breast cancer patients |
| Q46458165 | Low-Dose Pesticide Mixture Induces Senescence in Normal Mesenchymal Stem Cells (MSC) and Promotes Tumorigenic Phenotype in Premalignant MSC. |
| Q47701410 | Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications |
| Q36661456 | Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status |
| Q28085040 | Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds |
| Q102061308 | Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics |
| Q64076402 | Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice |
| Q39108175 | New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. |
| Q53071358 | Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation. |
| Q88034954 | Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence? |
| Q37328298 | Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept |
| Q34465559 | Selective augmentation of stem cell populations in structural fat grafts for maxillofacial surgery |
| Q38750240 | TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models |
| Q42084526 | The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. |
| Q37043780 | The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute |
| Q37912477 | The safety of autologous fat transfer in breast cancer: lessons from stem cell biology. |
| Q36194212 | Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion. |
| Q42320535 | Upper extremity sarcoma: impact of current practice guidelines and controversies on reconstructive approaches |
Search more.